Cargando…
Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules
Recently developed drug delivery nanosystems, such as lipid nanocapsules (LNCs), hold great promise for the treatment of glioblastomas (GBs). In this study, we used a subpopulation of human mesenchymal stem cells, “marrow-isolated adult multilineage inducible” (MIAMI) cells, which have endogenous tu...
Autores principales: | Clavreul, Anne, Montagu, Angélique, Lainé, Anne-Laure, Tétaud, Clément, Lautram, Nolwenn, Franconi, Florence, Passirani, Catherine, Vessières, Anne, Montero-Menei, Claudia N, Menei, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335613/ https://www.ncbi.nlm.nih.gov/pubmed/25709447 http://dx.doi.org/10.2147/IJN.S69175 |
Ejemplares similares
-
Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma
por: Clavreul, Anne, et al.
Publicado: (2018) -
Human mesenchymal stromal cells as cellular drug-delivery vectors for glioblastoma therapy: a good deal?
por: Clavreul, Anne, et al.
Publicado: (2017) -
Mesenchymal Stromal-Like Cells in the Glioma Microenvironment: What Are These Cells?
por: Clavreul, Anne, et al.
Publicado: (2020) -
Nanocarriers and nonviral methods for delivering antiangiogenic factors for glioblastoma therapy: the story so far
por: Clavreul, Anne, et al.
Publicado: (2019) -
A Simple Preoperative Blood Count to Stratify Prognosis in Isocitrate Dehydrogenase-Wildtype Glioblastoma Patients Treated with Radiotherapy plus Concomitant and Adjuvant Temozolomide
por: Clavreul, Anne, et al.
Publicado: (2021)